HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SRL172

used with standard chemotherapy (mitomycin-C, vinblastine and cisplatin) in patients with malignant mesothelioma
Also Known As:
SRL 172
Networked: 26 relevant articles (6 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. O'Brien, M E R: 5 articles (01/2008 - 02/2002)
2. Stanford, J L: 3 articles (09/2008 - 02/2003)
3. Smith, I E: 3 articles (02/2002 - 10/2000)
4. Mendes, R: 3 articles (02/2002 - 10/2000)
5. Souberbielle, B E: 3 articles (02/2002 - 10/2000)
6. Bromelow, K V: 3 articles (02/2002 - 10/2000)
7. Stanford, John: 2 articles (03/2010 - 06/2006)
8. Dlugovitzky, Diana: 2 articles (03/2010 - 06/2006)
9. Fiorenza, Gladys: 2 articles (03/2010 - 06/2006)
10. Stanford, Cynthia: 2 articles (03/2010 - 06/2006)

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Melanoma (Melanoma, Malignant)
3. Renal Cell Carcinoma (Grawitz Tumor)
4. Neoplasms (Cancer)
5. Adenocarcinoma

Related Drugs and Biologics

1. Interleukin-2 (IL2)
2. trastuzumab (Herceptin)
3. Mitomycin (Mitomycin-C)
4. Cytokines
5. Vinblastine (Vinblastine Sulfate)
6. Cisplatin (Platino)
7. Hepatitis B Vaccines (Hepatitis B Vaccine)
8. Hormones
9. Antigens
10. Immunologic Adjuvants (Immunologic Adjuvant)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Nephrectomy
4. Intradermal Injections
5. Injections